selegiline has been researched along with sildenafil citrate in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Csoka, AB; Shipko, S | 1 |
| Berner, MM; Hagen, M; Kriston, L | 2 |
| Berner, MM; Hagen, M; Kriston, L; Maayan, N; Schmidt, HM; Soares-Weiser, K | 1 |
| Chamanara, M; Dehpour, AR; Nikoui, V; Norouzi-Javidan, A; Ostadhadi, S; Shakiba, S; Zolfaghari, S | 1 |
3 review(s) available for selegiline and sildenafil citrate
| Article | Year |
|---|---|
A systematic review of research on strategies for the management of antipsychotic-induced sexual dysfunction: high-level evidence is needed.
Topics: Antipsychotic Agents; Erectile Dysfunction; Female; Humans; Male; Monoamine Oxidase Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Research; Research Design; Schizophrenia; Selegiline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Treatment Outcome | 2006 |
Management of sexual dysfunction due to antipsychotic drug therapy.
Topics: Antipsychotic Agents; Cross-Over Studies; Erectile Dysfunction; Female; Humans; Male; Piperazines; Purines; Randomized Controlled Trials as Topic; Selegiline; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2007 |
Management of sexual dysfunction due to antipsychotic drug therapy.
Topics: Antipsychotic Agents; Benzodiazepines; Cross-Over Studies; Drug Substitution; Erectile Dysfunction; Female; Humans; Male; Olanzapine; Piperazines; Purines; Randomized Controlled Trials as Topic; Selegiline; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2012 |
2 other study(ies) available for selegiline and sildenafil citrate
| Article | Year |
|---|---|
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
The role of nitric oxide-cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test.
Topics: Animals; Antidepressive Agents; Arginine; Cyclic GMP; Drug Synergism; Fluoxetine; Guanidines; Hippocampus; Immobility Response, Tonic; Indazoles; Male; Methylene Blue; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrites; Prefrontal Cortex; Selegiline; Signal Transduction; Sildenafil Citrate; Swimming | 2018 |